CytomX Therapeutics (CTMX) Other Non Operating Income (2014 - 2026)
CytomX Therapeutics (CTMX) posted Other Non Operating Income of -$7000.0 for Q1 2026, up 98.2% on a QoQ basis from -$388000.0 in Q4 2025, and down 163.64% year-over-year from $11000.0 in Q1 2025.
CytomX Therapeutics (CTMX) Other Non Operating Income (2014 - 2026) Analysis & Trends
CytomX Therapeutics' Other Non Operating Income history runs 13 years deep, the most recent figure standing at -$7000.0 for Q1 2026.
- Quarterly Other Non Operating Income fell 163.64% year-over-year to -$7000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$373000.0 (down 2094.12% YoY) and the FY2025 annual result came in at -$355000.0, down 834.21% from the prior year.
- Other Non Operating Income was -$7000.0 for Q1 2026 at CytomX Therapeutics, up from -$388000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $296000.0 in Q2 2022 and bottomed at -$388000.0 in Q4 2025.
- A 5-year average of -$5352.9 and a median of $1000.0 in 2022 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 950.0% in 2025, while the deepest fall reached 1942.11% in 2025.
- CytomX Therapeutics' Other Non Operating Income stood at $1000.0 in 2022, then jumped by 800.0% to $9000.0 in 2023, then plunged by 311.11% to -$19000.0 in 2024, then slumped by 1942.11% to -$388000.0 in 2025, then soared by 98.2% to -$7000.0 in 2026.
- Business Quant data shows CTMX's Other Non Operating Income at -$7000.0 in Q1 2026, -$388000.0 in Q4 2025, and $5000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | CytomX Therapeutics | 574.36 Mn | 227.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,000.00 |
| Dec 31, 2025 | -388,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | -19,000.00 |
| Sep 30, 2024 | -7,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Sep 30, 2023 | -7,000.00 |
| Jun 30, 2023 | -47,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | 30,000.00 |
| Jun 30, 2022 | 296,000.00 |
| Mar 31, 2022 | 13,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | -13,000.00 |
| Jun 30, 2021 | -82,000.00 |